OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Rita E. Numerof, PhD, is the president at Numerof & Associates, Inc.
The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.
The industry must be prepared for the impact of the sweeping changes expected from the new legislation.